Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The kappa opioid receptor (KOR) is a G protein-coupled receptor that primarily binds dynorphins. It mediates various physiological processes including analgesia (without respiratory depression), diuresis, and dysphoria. Due to its role in pain modulation and reward pathways, it is a target for novel analgesics and treatments for addiction and mood disorders.
Gi/o protein coupling that suppresses adenylyl cyclase activity, leading to reduced cAMP levels within cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Opioid Receptor Kappa-Type (KOR).